News

image of CAR-T cells and lymphoma cells in the lymph node and cell culture

2024 Dec 05

Anticancer Drugs Could Make Immunotherapies More Effective

An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by Weill Cornell Medicine lymphoma researchers. The inhibitors... Read more

2024 Dec 03

DNA Secreted by Tumor Cell Extracellular Vesicles Prompts Anti-Metastatic Immune Response

Specially packaged DNA secreted by tumor cells can trigger an immune response that inhibits the metastatic spread of the tumor to the liver, according to a study led by researchers at Weill Cornell Medicine, Memorial Sloan... Read more

Immunofluorescence image of purple and green cells

2024 Nov 20

Study Unveils Key Strategies Against Drug-Resistant Prostate Cancer

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine. The results could potentially lead to... Read more

2024 Nov 14

Yes, You Need This Pancreatic Cancer Primer

Approximately six inches long, the pancreas is tucked between your stomach and spine . There, it assists in controlling your blood sugar levels by helping to create enzymes that break down food . When cancer settles in,... Read more

2024 Nov 07

Virtual Screening Identifies Potential Small Molecule Drugs for Cancer Immunotherapy

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual screening, according to Weill Cornell Medicine researchers. Checkpoint... Read more

2024 Oct 30

New Starr Cancer Consortium Grants Awarded to Weill Cornell Medicine Researchers

Three teams led by Weill Cornell Medicine scientists have received awards from the Starr Cancer Consortium in its 17th and final annual grant competition. The grants will fund research on the deep mechanisms of common... Read more

2024 Oct 23

Discovery Finds How Ovarian Cancer Disables Immune Cells

Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede their attack—blocking the energy supply T cells depend on. The study , published Oct. 23 in Nature,... Read more

2024 Oct 22

How Melanoma Cells Escape Oxidative Stress to Metastasize

Investigators from Weill Cornell Medicine have discovered a defense mechanism that protects skin cancer cells from oxidative stress and helps them spread. The findings suggest a new drug target that could lead to therapies... Read more

2024 Oct 16

NEW MEYER CANCER CENTER CLINICAL RESEARCH LEADERSHIP TEAM

The Sandra and Edward Meyer Cancer Center (MCC) of Weill Cornell Medicine and NewYork- Presbyterian Hospital is pleased to announce a new cancer clinical research leadership team: Vered Stearns, MD is Associate Director for... Read more

2024 Oct 15

Love Your Breasts, Each and Every Year

Previously, women were encouraged to develop a personalized breast cancer screening program starting in their 40s. For some women, that meant no mammogram until age 50. That’s all changed. T he U.S. Preventive Services Task... Read more

Artistic rendition of extrachromosomal DNA and chromosomes

2024 Oct 09

Study Uncovers Mutations and DNA Structures Driving Bladder Cancer

How bladder cancer originates and progresses has been illuminated as never before in a study led by researchers at Weill Cornell Medicine and the New York Genome Center . The researchers found that antiviral enzymes that... Read more

This image shows a triple-negative breast cancer cell undergoing cell death after treatment with a combination of chemotherapy and a second targeted drug. Actin in red; mitochondria in green; nuclei in blue. Credit: National Cancer Institute

2024 Oct 04

New Genetic Signatures Can Classify Breast Cancers and Guide Prognosis

Researchers at Weill Cornell Medicine have developed breast cancer cell-of-origin signatures that can better predict both overall and progression-free survival of patients with breast cancer compared to previously developed... Read more

immunofluorescence image of pancreatic cancer cells labeled in various colors

2024 Oct 02

Researchers Develop Insights into KRAS Mutations in Pancreatic Cancers

A common mutation in the KRAS gene is associated with improved overall survival in pancreatic ductal adenocarcinoma (PDAC) compared with other variants, in part because the mutation appears to lead to less invasiveness and... Read more

Human lung cancer cells stained for various surface markers

2024 Sep 26

Metabolic Reprogramming of T cells May Enhance Checkpoint Inhibitor Therapy

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune checkpoint inhibitor therapy, according to a preclinical study led by researchers at Weill Cornell... Read more

2024 Sep 24

New Tool Quantifies Cancer’s Ability to Shape-Shift

A powerful new analytical tool offers a closer look at how tumor cells “shape-shift” to become more aggressive and untreatable, as shown in a study from researchers at Weill Cornell Medicine and the New York Genome Center ... Read more

2024 Sep 23

Innovative Model Provides Valuable Insights into Prostate Cancer Spread

A new preclinical model using CRISPR, an advanced technology that allows scientists to cut and edit genes, has given Weill Cornell Medicine researchers and their colleagues a deeper insight into how prostate cancer spreads... Read more

man sitting on hospital bed talking to doctor in a chair

2024 Sep 19

New Prostate Biopsy Technique Lowers Infection Risk

A multi-institutional clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators showed that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with... Read more

blue cell and red cell interaction blocked by blue and red antibodies

2024 Sep 15

Long-term Metastatic Melanoma Survival Dramatically Improves on Immunotherapy

Long-term data from a landmark international trial show about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or more, according to a new... Read more

2024 Sep 12

Meyer Cancer Center Appoints Inaugural DEI Leadership Team

The Sandra and Edward Meyer Cancer Center (MCC) of Weill Cornell Medicine and NewYork- Presbyterian Hospital has appointed a trio of outstanding physicians and researchers to oversee the Center’s first Office of Diversity... Read more

2024 Sep 05

Computational Approach Yields Novel Cancer Targets

Researchers at Weill Cornell Medicine have used artificial intelligence to identify drug targets based on mapping regulatory networks in patient tumors. The study , published Sept. 4 in Cell Systems, experimentally... Read more